Mutational analysis of PPARG as a candidate tumour suppressor gene in enteropancreatic endocrine tumours

Clinical Endocrinology

Volumn 62, Issue 5, 2005, Pages 603-606

  Costa Guda, Jessica ^a   Rosen, Evan D ^b   Jensen, Robert T ^c   Chung, Daniel C ^d   Arnold, Andrew ^a,e  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ARTICLE; CHROMOSOME 3P; CHROMOSOME DELETION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; ENDOCRINE TUMOR; ENTEROPANCREATIC ENDOCRINE TUMOR; GENE; GENE FUNCTION; GENE INACTIVATION; HETEROZYGOSITY LOSS; HUMAN; KNOCKOUT MOUSE; MICROSATELLITE MARKER; MOUSE; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET CELL; PANCREAS ISLET CELL HYPERPLASIA; PATHOGENESIS; PPARG GENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

DNA MUTATIONAL ANALYSIS; ENDOCRINE GLAND NEOPLASMS; GENES, TUMOR SUPPRESSOR; HUMANS; INTESTINAL NEOPLASMS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; PANCREATIC NEOPLASMS; PPAR GAMMA;

EID: 18444390578     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02267.x     Document Type: Article

References (34)

1. Lubensky, I. (2002) Endocrine PANCREAS. In: V. LiVolsi ed. Endocrine Pathology. Churchill Livingstone, Philadelphia, 205-235.
2. Debelenko, L.V., Zhuang, Z., Emmert-Buck, M.R., Chandrasekharappa, S.C., Manickam, P., Guru, S.C., Marx, S.J., Skarulis, M.C., Spiegel, A.M., Collins, F.S., Jensen, R.T., Liotta, L.A. & Lubensky, I.A. (1997) Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Research, 57, 2238-2243.
3. Zhuang, Z., Vortmeyer, A.O., Pack, S., Huang, S., Pham, T.A., Wang, C., Park, W.S., Agarwal, S.K., Debelenko, L.V., Kester, M., Guru, S.C., Manickam, P., Olufemi, S.E., Yu, F., Heppner, C, Crabtree, J.S., Skarulis, M.C., Venzon, D.J., Emmert-Buck, M.R., Spiegel, A.M., Chandrasekharappa, S.C., Collins, F.S., Burns, A.L., Marx, S.J. & Lubensky, I.A. (1997) Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Research, 57, 4682-4686.
4. Chandrasekharappa, S.C., Guru, S.C., Manickam, P., Olufemi, S.E., Collins, P.S., Emmert-Buck, M.R., Debelenko, L.V., Zhuang, Z., Lubensky, I.A., Liotta, L.A., Crabtree, J.S., Wang, Y., Roe, B.A., Weisemann, I., Boguski, M.S., Agarwal, S.K., Kester, M.B., Kim, Y.S., Heppner, C., Dong, Q., Spiegel, A.M., Burns, A.L. & Marx, S.J. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science, 276, 404-407.
5. Chung, D.C., Smith, A.P., Louis, D.N., Graeme-Cook, F., Warshaw, A.L. & Arnold, A. (1997) A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. Journal of Clinical Investigation, 100, 404-410.
6. Chung, D.C., Smith, A.P., Louis, D.N., Graeme-Cook, F., Warshaw, A.L. & Arnold, A. (1997) Analysis of the retinoblastoma tumour suppressor gene in pancreatic endocrine tumours. Clinical Endocrinology, 47, 523-528.
7. Yoshimoto, K., Iwahana, H., Fukuda, A., Sano, T., Saito, S. & Itakura, M. (1992) Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Cancer Research, 52, 5061-5064.
8. Perren, A., Komminoth, P., Saremaslani, P., Matter, C., Feurer, S., Lees, J.A., Heitz, P.U. & Eng, C. (2000) Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. American Journal of Pathology, 157, 1097-1103.
9. Pellegata, N.S., Sessa, F., Renault, B., Bonato, M., Leone, B.E., Solcia, E. & Ranzani, G.N. (1994) K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Research, 54, 1556-1560.
10. Bartsch, D., Hahn, S.A., Danichevski, K.D., Ramaswamy, A., Bastian, D., Galehdari, H., Schmiegel, W., Simon, B. & Rothmund, M. (1999) Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors. Oncogene, 18, 2367-2371.
11. Perren, A., Saremaslani, P., Schmid, S., Bonvin, C., Locher, T., Roth, J., Heitz, P.U. & Komminoth, P. (2003) DPC4/Smad4: no mutations, rare allelic imbalances, and retained protein expression in pancreatic endocrine tumors. Diagnostic Molecular Pathology, 12, 181-186.
12. Moore, P.S., Orlandini, S., Zamboni, G., Capelli, P., Rigaud, G., Falconi, M., Bassi, C., Lemoine, N.R. & Scarpa, A. (2001) Pancreatic tumours: molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis. British Journal of Cancer, 84, 253-262.
13. Muscarella, P., Melvin, W.S., Fisher, W.E., Foor, J., Ellison, E.G., Herman, J.G., Schirmer, W.J., Hitchcock, C.L., De Young, B.R. & Weghorst, C.M. (1998) Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: an analysis of p16/MTS1 tumor suppressor gene inactivation. Cancer Research, 58, 237-240.
14. Serrano, J., Goebel, S.U., Peghini, P.L., Lubensky, I.A., Gibril, F. & Jensen, R.T. (2000) Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas. Journal of Clinical Endocrinology and Metabolism, 85, 4146-4156.
15. Bartsch, D.K., Kersting, M., Wild, A., Ramaswamy, A., Gerdes, B., Schuermann, M., Simon, B. & Rothmund, M. (2000) Low frequency of p16 (INK4a) alterations in insulinomas. Digestion, 62, 171-177.
16. Evers, B.M., Rady, P.L., Sandoval, K., Arany, I., Tyring, S.K., Sanchez, R.L., Nealon, W.H., Townsend, C.M. & Thompson, J.C. (1994) Gastrinomas demonstrate amplification of the HER-2/neu proto-oncogene. Annals of Surgery, 219, 596-604.
17. Terris, B., Meddeb, M., Marchio, A., Danglot, G., Flejou, J.F., Belghiti, J., Ruszniewski, P. & Bernheim, A. (1998) Comparative genomic hybridization analysis of sporadic neuroendocrine tumors of the digestive system. Genes Chromosomes Cancer, 22, 50-56.
18. Chung, D.C., Brown, S.B., Graeme-Cook, F., Tillotson, L.G., Warshaw, A.L., Jensen, R.T. & Arnold, A. (1998) Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors. Cancer Research, 58, 3706-3711.
19. Guo, S.S., Arora, C., Shimoide, A.T. & Sawicki, M.P. (2002) Frequent deletion of chromosome 3 in malignant sporadic pancreatic endocrine tumors. Molecular and Cellular Endocrinology, 190, 109-114.
20. Nikiforova, M.N., Nikiforov, Y.E., Biddinger, P., Gnepp, D.R., Grosembacher, L.A., Wajchenberg, B.L., Fagin, J.A. & Cohen, R.M. (1999) Frequent loss of heterozygosity at chromosome 3p14.2-3p21 in human pancreatic islet cell tumours. Clinical Endocrinology, 51, 27-33.
21. Speel, E.J., Richter, J., Moch, H., Egenter, C., Saremaslani, P., Rutimann, K., Zhao, J., Barghorn, A., Roth, J., Heitz, P.U. & Komminoth, P. (1999) Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. American Journal of Pathology, 155, 1787-1794.
22. Dubois, M., Pattou, F., Kerr-Conte, J., Gmyr, V., Vandewalle, B., Desreumaux, P., Auwerx, J., Schoonjans, K. & Lefebrve, J. (2000) Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in normal human pancreatic islet cells. Diabetalogia, 43, 1165-1169.
23. Spiegelman, B.M. (1998) PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes, 47, 507-514.
24. Brockman, J.A., Gupta, R.A. & Dubois, R.N. (1998) Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology, 115, 1049-1055.
25. Kitamura, S., Miyazaki, Y., Hiraoka, S., Toyota, M., Nagasawa, Y., Kondo, S., Kiyohara, T., Shinomura, Y. & Matsuzawa, Y. (1999) PPARgamma inhibits the expression of C-MET in human gastric cancer cells through the suppression of Ets. Biochemical and Biophysical Research Communications, 265, 453-456.
26. Chung, D.C., Brown, S.B., Graeme-Cook, F., Seto, M., Warshaw, A.L., Jensen, R.T. & Arnold, A. (2000) Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. Journal of Clinical Endocrinology and Metabolism, 85, 4373-4378.
27. Sarraf, P., Mueller, E., Smith, W.M., Wright, H.M., Kum, J.B., Aaltonen, L.A., de la Chapelle, A., Spiegelman, B.M. & Eng, C. (1999) Loss-of-function mutations in PPAR gamma associated with human colon cancer. Molecular Cell, 3, 799-804.
28. Ikezoe, T., Miller, C.W., Kawano, S., Heaney, A., Williamson, E.A., Hisatake, J., Green, E., Hofman, W., Taguchi, H. & Koeffler, H.P. (2001) Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies. Cancer Research, 61, 5307-5310.
29. Koeffler, H.P. (2003) Peroxisome proliferator-activated receptor gamma and cancers. Clinical Cancer Research, 9, 1-9.
30. Rosen, E.D., Kulkarni, R.N., Sarraf, P., Ozcan, U., Okada, T., Hsu, C.H., Eisenman, D., Magnuson, M.A., Gonzalez, F.J., Kahn, C.R. & Spiegelman, B.M. (2003) Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis. Molecular and Cellular Biology, 23, 7222-7229.
31. Shattuck, T.M., Costa, J., Bernstein, M., Jensen, R.T., Chung, D.C. & Arnold, A. (2002) Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-beta and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors. Journal of Clinical Endocrinology and Metabolism, 87, 3911-3914.
32. Rozen, S, Skaletsky, H. (2000) Primer3 on the WWW for general users and for biologist programmers. Methods in Molecular Biology, 132, 365-386.
33. Haber, D. & Harlow, E. (1997) Tumour-suppressor genes: evolving definitions in the genomic age. Nature Genetics, 16, 320-322.
34. Vogelstein, B. & Kinzler, K.W. (2004) Cancer genes and the pathways they control. Nature Medicine, 10, 789-799.